Cite
Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Non-Diabetic Patients with Stage 2-4 Chronic Kidney Disease.
MLA
Malyszko, Jolanta, et al. “Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Non-Diabetic Patients with Stage 2-4 Chronic Kidney Disease.” Renal Failure, vol. 30, no. 6, July 2008, pp. 625–28. EBSCOhost, https://doi.org/10.1080/08860220802134607.
APA
Malyszko, J., Bachorzewska-Gajewska, H., Sitniewska, E., Malyszko, J. S., Poniatowski, B., & Dobrzycki, S. (2008). Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Non-Diabetic Patients with Stage 2-4 Chronic Kidney Disease. Renal Failure, 30(6), 625–628. https://doi.org/10.1080/08860220802134607
Chicago
Malyszko, Jolanta, Hanna Bachorzewska-Gajewska, Ewa Sitniewska, Jacek S. Malyszko, Boguslaw Poniatowski, and Slawomir Dobrzycki. 2008. “Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Non-Diabetic Patients with Stage 2-4 Chronic Kidney Disease.” Renal Failure 30 (6): 625–28. doi:10.1080/08860220802134607.